Menu Back toSession-0704-Development-of-Biosimilars-in-China-Interpretation-of-Biosimilar-Guidance-Opportunities-and-Challenges-II

The 7th DIA China Annual Meeting


Session 0704 Development of Biosimilars in China: Interpretation of Biosimilar Guidance, Opportunities and Challenges - II

Session Chair(s)

Joe  Zhang

Joe Zhang

  • Co-founder and CEO
  • BJ Bioscience Inc., China

Science Based BiosimilarRegulatory Pathway

Speaker(s)

Weidong  Jiang

Weidong Jiang

  • Chief Strategy Officer and Senior Vice President
  • Henlius, China
Irene  Deng

Science Based BiosimilarRegulatory Pathway

Irene Deng

  • Head of Regulatory Affairs, China
  • Sanofi, China
Cindy  Xu

Cindy Xu

  • Henlius, China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650